"Das Ev. Krankenhaus Mülheim (EKM) ist ein Akutkrankenhaus mit 602 Betten in Trägerschaft der ATEGRIS. Mehr als 1.000 Mitarbeiter versorgen jährlich über 21.000 stationäre und 60.000 ambulante Patienten. Das Haus deckt mit 15 Fachkliniken und sechs zertifizierten Zentren nahezu das komplette Spektrum modernster Medizin und Pflege ab. Als Arbeitgeber steht das EKM für ein familienfreundliches Arbeitsumfeld, eine hohe Werteorientierung und eine Verknüpfung aus Tradition und Innovation. Außerdem nimmt das EKM als akademisches Lehrkrankenhaus der Universität Düsseldorf an der Lehre und Ausbildung von Medizinstudenten teil."

During the past decade, Evangelisches Krankenhaus Mülheim conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Evangelisches Krankenhaus Mülheim" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator and "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Evangelisches Krankenhaus Mülheim" are "Heart Failure" (2 trials), "Cheyne Stokes Respiration" (1 trials), "Congestive Heart Failure" (1 trials), "Coronary Artery Stenosis" (1 trials) and "Left Ventricular Systolic Dysfunction" (1 trials). Many other conditions were trialed in "Evangelisches Krankenhaus Mülheim" in a lesser frequency.

Most popular intervention types in "Evangelisches Krankenhaus Mülheim" are "Device" (3 trials), "Biological" (1 trials), "Drug" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABSORB Scaffold" (1 trials), "EPOCH regimen" (1 trials), "Europe: AutoSet CS (USA: VPAP Adapt SV)" (1 trials), "adaptive servoventilation (ASV)" (1 trials) and "cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Evangelisches Krankenhaus Mülheim" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Evangelisches Krankenhaus Mülheim". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Evangelisches Krankenhaus Mülheim, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Evangelisches Krankenhaus Mülheim, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".